Efficient Machine Learning Pipeline Predicts Nanoscale Interactions Location

Date:

A new machine learning tool called NeCLAS, developed by researchers at the University of Michigan, can predict how proteins and nanoparticles might interact, including predicting binding sites and the likelihood of binding between them. This new tool could aid in the fight against antibiotic-resistant infections and new viruses, by designing drugs that target crucial proteins in bacteria and viruses without harming human cells. NeCLAS uses structural models of proteins and their known interaction sites to extrapolate how proteins and nanoparticles might interact and predict interactions between two proteins or two nanoparticles. This enables researchers to understand the potential applications of nanoparticles and optimize their designs. The tool was tested with three case studies, showing the potential of the tool in optimizing designs and predicting interactions. The study was funded by the Army Research Office, National Science Foundation and the University of Michigan Blue Sky Initiative.

See also  Breakthrough Machine Learning System Predicts Mortality Rates

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.